Revolution Ascend
GE Healthcare Japan Corporation • Radiology • 11/20/2020
Device Purpose
The Revolution Ascend is an advanced computed tomography system designed to provide comprehensive diagnostic imaging across a wide range of clinical applications, including head, whole body, cardiac, and vascular imaging for all patient ages, by employing X-ray transmission and sophisticated computer reconstruction techniques. It enhances imaging capabilities and workflow through a wider gantry bore, physical tilt, and the integration of artificial intelligence features such as deep learning for auto-positioning and machine learning for intelligent protocoling.
Summary
The Revolution Ascend is a computed tomography (CT) X-ray system designed to produce cross-sectional images of the body, including the head, whole body, cardiac, and vascular systems, for patients of all ages. It operates by utilizing computer reconstruction of X-ray transmission data acquired from various angles and planes through methods such as Axial, Cine, Helical (Volumetric), Cardiac, and Gated acquisitions, which can be performed with or without contrast media. The system encompasses signal analysis and display equipment, patient and equipment supports, and associated components, and is capable of data and image processing to generate images in multiple trans-axial and reformatted planes, with options for post-processing for additional imaging planes or analysis. Its primary purpose is to serve as a valuable medical tool for diagnosing diseases, trauma, or abnormalities, as well as for planning, guiding, and monitoring therapeutic interventions. The Revolution Ascend builds upon the fundamental operating principles of its predicate device, the Revolution Maxima, but introduces significant technological enhancements. Key changes include a widened gantry bore (75cm) to better accommodate large patients, trauma examinations, interventional procedures, and radiotherapy planning, along with a physical gantry tilt mechanism. It features a modernized software platform and graphical user interface, and integrates several advanced functionalities ported from other GE CT systems. These include Auto Pilot workflow enabled by Deep Learning-based patient Auto Positioning, Intelligent Protocoling utilizing Machine Learning, Smart Plan, Auto Prescription, Auto Gating for cardiac imaging, and 3D Guidance for interventional procedures. Non-clinical performance testing, including image quality and dose evaluations using phantoms under various conditions, demonstrated that the Revolution Ascend performs equivalently to its predicate device.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the Deep Learning-based Auto Positioning feature specifically improve workflow efficiency or patient throughput compared to manual positioning techniques?; What are the quantitative differences in image noise or artifact reduction attributable to the Revolution Ascend's gantry design and reconstruction algorithms, particularly for bariatric patients or complex cardiac scans?; Can the Intelligent Protocoling system, enabled by Machine Learning, adapt in real-time to unexpected patient-specific anatomical variations or conditions encountered mid-scan?; What is the measurable impact of the 75cm gantry bore and physical tilt on the range of interventional procedures feasible or the precision of radiotherapy planning setups compared to systems with smaller bores or digital tilt?; Are there specific cardiac conditions or patient populations where the combination of Auto Gating and other new cardiac features in Revolution Ascend demonstrably improves diagnostic accuracy or reduces scan time over previous generation CT systems?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly